Cargando…

A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor

The global outbreak of COVID-19 (Coronavirus Disease 2019) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome caused by Coronavirus 2) began in December 2019. Its closest relative, SARS-CoV-1, has a slightly mutated Spike (S) protein, which interacts with ACE2 receptor in human cells to start t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souza, Pedro F.N., Lopes, Francisco E.S., Amaral, Jackson L., Freitas, Cleverson D.T., Oliveira, Jose T.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368152/ https://www.ncbi.nlm.nih.gov/pubmed/32693122 http://dx.doi.org/10.1016/j.ijbiomac.2020.07.174

Ejemplares similares

Neutralizing Effect of Synthetic Peptides toward SARS-CoV-2
por: Souza, Pedro F.N., et al.
Publicado: (2022)

Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin
por: Bhanu, Piyush, et al.
Publicado: (2020)

Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking
por: Yu, Ran, et al.
Publicado: (2022)

Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM
por: Xu, Cong, et al.
Publicado: (2021)

Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Controlling the SARS-CoV-2 spike glycoprotein conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Conformational stability of SARS-CoV-2 glycoprotein spike variants
por: Arruda, Hiam R.S., et al.
Publicado: (2022)

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
por: Prévost, Jérémie, et al.
Publicado: (2021)

Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2
por: Mendis, Jenny, et al.
Publicado: (2021)

The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
por: Souza, Pedro F.N., et al.
Publicado: (2022)

Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction
por: Guimond, Scott E., et al.
Publicado: (2022)

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
por: Wrobel, Antoni G., et al.
Publicado: (2020)

FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein
por: Serrão, Vitor Hugo B., et al.
Publicado: (2020)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play
por: Souza, Pedro F.N., et al.
Publicado: (2021)

Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
por: Rathod, Shravan B., et al.
Publicado: (2020)

Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor
por: Durmaz, Bengül, et al.
Publicado: (2020)

Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
por: Singh, Jitender, et al.
Publicado: (2021)

Insights from the molecular docking analysis of gambogic acid with the Chikungunya spike glycoprotein E2
por: Qamar, Sadia, et al.
Publicado: (2023)

Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
por: Lee, Myeongsang, et al.
Publicado: (2023)

Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2
por: Shen, Min, et al.
Publicado: (2020)

Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2
por: Priya, Prerna, et al.
Publicado: (2021)

Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2
por: Golcuk, Mert, et al.
Publicado: (2022)

Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
por: Song, Wenfei, et al.
Publicado: (2018)

Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective
por: Duru, Chidi Edbert, et al.
Publicado: (2021)

Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2
por: Hayashi, Takuma, et al.
Publicado: (2021)

SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals
por: Praharaj, Manas Ranjan, et al.
Publicado: (2022)

Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
por: Basu, Anamika, et al.
Publicado: (2020)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
por: Francesconi, Oscar, et al.
Publicado: (2022)

The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies
por: Papageorgiou, Anastassios C., et al.
Publicado: (2020)

Structure/Function Analysis of Truncated Amino-Terminal ACE2 Peptide Analogs That Bind to SARS-CoV-2 Spike Glycoprotein
por: Mackin, Robert T., et al.
Publicado: (2022)

Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation
por: McCallum, Matthew, et al.
Publicado: (2020)

Biochemical Analysis of Coronavirus Spike Glycoprotein Conformational Intermediates during Membrane Fusion
por: Kawase, Miyuki, et al.
Publicado: (2019)

Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions
por: Hussain, Mushtaq, et al.
Publicado: (2020)

Pierce into Structural Changes of Interactions Between Mutated Spike Glycoproteins and ACE2 to Evaluate Its Potential Biological and Therapeutic Consequences
por: Hashemi, Zahra Sadat, et al.
Publicado: (2021)

Conformational dynamics of the Beta and Kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM
por: Wang, Yifan, et al.
Publicado: (2021)

Mass photometry reveals SARS-CoV-2 spike stabilisation to impede ACE2 binding through altered conformational dynamics
por: Burnap, Sean A., et al.
Publicado: (2022)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation
por: Schoof, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i904e03lurav68uke3240ounpp